Maria Soroka‐Wojtaszko
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study(2020)334 cited
- Thalidomide treatment of resistant or relapsed multiple myeloma patients.(2001)
- → Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial(2023)80 cited
- → Production of Proangiogenic Cytokines During Thalidomide Treatment of Multiple Myeloma(2002)37 cited
- → An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma(2004)15 cited
- Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.(2006)
- Influence of lovastatin on BCL-2 and BAX expression by plasma cells and T lymphocytes in short-term cultures of multiple myeloma bone marrow mononuclear cells.(2005)
- → New prognostic biomarkers in multiple myeloma(2016)7 cited
- → Analysis of the PD-1/PD-L1 Axis Points to Association of Unfavorable Recurrent Mutations with PD-L1 Expression in AML(2016)5 cited